183 related articles for article (PubMed ID: 34514995)
1. An Overview on the Role of miR-451 in Lung Cancer: Diagnosis, Therapy, and Prognosis.
Soofiyani SR; Hosseini K; Soleimanian A; Abkhooei L; Hoseini AM; Tarhriz V; Ghasemnejad T
Microrna; 2021; 10(3):181-190. PubMed ID: 34514995
[TBL] [Abstract][Full Text] [Related]
2. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
3. Clinical implication of microrna for lung cancer.
Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
[TBL] [Abstract][Full Text] [Related]
4.
Wang JY; Zhang Q; Wang DD; Yan W; Sha HH; Zhao JH; Yang SJ; Zhang HD; Hou JC; Xu HZ; He YJ; Hu JH; Zhong SL; Tang JH
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29217524
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer.
Tang S; Li S; Liu T; He Y; Hu H; Zhu Y; Tang S; Zhou H
Cancer Lett; 2021 Apr; 502():71-83. PubMed ID: 33453304
[TBL] [Abstract][Full Text] [Related]
7. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
8. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
9. [MiR-128, a key regulator of oncogenic properties].
Huang DQ; Guo P; Lv NH; Luo LY
Mol Biol (Mosk); 2015; 49(1):46-54. PubMed ID: 25916109
[TBL] [Abstract][Full Text] [Related]
10. Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration.
Mohammadi A; Mansoori B; Duijf PHG; Safarzadeh E; Tebbi L; Najafi S; Shokouhi B; Sorensen GL; Holmskov U; Baradaran B
J Cell Physiol; 2021 Jan; 236(1):273-283. PubMed ID: 32583462
[TBL] [Abstract][Full Text] [Related]
11. The novel miR-9501 inhibits cell proliferation, migration and activates apoptosis in non-small cell lung cancer.
Xi Y; Wang L; Sun C; Yang C; Zhang F; Li D
Med Oncol; 2016 Nov; 33(11):124. PubMed ID: 27734264
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
[TBL] [Abstract][Full Text] [Related]
13. The miRNA hsa-miR-6515-3p potentially contributes to lncRNA H19-mediated-lung cancer metastasis.
Xu Y; Lin J; Jin Y; Chen M; Zheng H; Feng J
J Cell Biochem; 2019 Oct; 120(10):17413-17421. PubMed ID: 31131469
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of miRNA-216b in cancer.
Jana S; Krishna M; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
Cancer Lett; 2020 Aug; 484():16-28. PubMed ID: 32387443
[TBL] [Abstract][Full Text] [Related]
15. The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy.
Alizadeh M; Safarzadeh A; Beyranvand F; Ahmadpour F; Hajiasgharzadeh K; Baghbanzadeh A; Baradaran B
J Cell Physiol; 2019 Nov; 234(11):19280-19297. PubMed ID: 30950056
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.
Zhou Q; Huang SX; Zhang F; Li SJ; Liu C; Xi YY; Wang L; Wang X; He QQ; Sun CC; Li DJ
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990243
[TBL] [Abstract][Full Text] [Related]
17. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.
Mirzadeh Azad F; Naeli P; Malakootian M; Baradaran A; Tavallaei M; Ghanei M; Mowla SJ
Gene; 2016 Feb; 577(2):221-6. PubMed ID: 26642897
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review on miR-451: A promising cancer biomarker with therapeutic potential.
Khordadmehr M; Jigari-Asl F; Ezzati H; Shahbazi R; Sadreddini S; Safaei S; Baradaran B
J Cell Physiol; 2019 Dec; 234(12):21716-21731. PubMed ID: 31140618
[TBL] [Abstract][Full Text] [Related]
20. Identifying circulating miRNA biomarkers for early diagnosis and monitoring of lung cancer.
Zhang YH; Jin M; Li J; Kong X
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165847. PubMed ID: 32473385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
